Global Meningococcal Vaccines Market Insights, Size, Share, Growth Opportunities, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028
| Report ID : 201536 | No. of Pages : 180
The research team projects that the Meningococcal Vaccines market size will grow from XXX in 2021 to XXX by 2028, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2021 to 2028.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
GlaxoSmithKline
JN-International Medical
Novartis International
Sanofi
Pfizer
Baxter International
By Type
Menactra
Menomune
By Application
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Meningococcal Vaccines 2015-2020, and development forecast 2021-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Meningococcal Vaccines Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Meningococcal Vaccines Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Meningococcal Vaccines market in 2020.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Table of Contents
1 Industry Overview
1.1 Meningococcal Vaccines Industry
Figure Meningococcal Vaccines Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Meningococcal Vaccines
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Meningococcal Vaccines
1.2.2 Downstream
Table Application Segment of Meningococcal Vaccines
Table Global Meningococcal Vaccines Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Meningococcal Vaccines Market by Type
3.1 By Type
3.1.1 Menactra
Table Major Company List of Menactra
3.1.2 Menomune
Table Major Company List of Menomune
3.2 Market Size
Table Global Meningococcal Vaccines Market 2016-2020, by Type, in USD Million
Figure Global Meningococcal Vaccines Market Growth 2016-2020, by Type, in USD Million
Table Global Meningococcal Vaccines Market 2016-2020, by Type, in Volume
Figure Global Meningococcal Vaccines Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Meningococcal Vaccines Market Forecast 2021-2026, by Type, in USD Million
Table Global Meningococcal Vaccines Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 GlaxoSmithKline (Company Profile, Sales Data etc.)
4.1.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
4.1.2 GlaxoSmithKline Products & Services
4.1.3 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 JN-International Medical (Company Profile, Sales Data etc.)
4.2.1 JN-International Medical Profile
Table JN-International Medical Overview List
4.2.2 JN-International Medical Products & Services
4.2.3 JN-International Medical Business Operation Conditions
Table Business Operation of JN-International Medical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Novartis International (Company Profile, Sales Data etc.)
4.3.1 Novartis International Profile
Table Novartis International Overview List
4.3.2 Novartis International Products & Services
4.3.3 Novartis International Business Operation Conditions
Table Business Operation of Novartis International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Sanofi (Company Profile, Sales Data etc.)
4.4.1 Sanofi Profile
Table Sanofi Overview List
4.4.2 Sanofi Products & Services
4.4.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Pfizer (Company Profile, Sales Data etc.)
4.5.1 Pfizer Profile
Table Pfizer Overview List
4.5.2 Pfizer Products & Services
4.5.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Baxter International (Company Profile, Sales Data etc.)
4.6.1 Baxter International Profile
Table Baxter International Overview List
4.6.2 Baxter International Products & Services
4.6.3 Baxter International Business Operation Conditions
Table Business Operation of Baxter International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Meningococcal Vaccines Sales Revenue 2016-2020, by Company, in USD Million
Table Global Meningococcal Vaccines Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Meningococcal Vaccines Sales Revenue Share in 2020, by Company, in USD Million
Table Global Meningococcal Vaccines Sales Volume 2016-2020, by Company, in Volume
Table Global Meningococcal Vaccines Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Meningococcal Vaccines Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Meningococcal Vaccines Market Concentration, in 2020
Figure Europe Meningococcal Vaccines Market Market Concentration, in 2020
Figure Asia-Pacific Meningococcal Vaccines MMarket Concentration, in 2020
Figure South America Meningococcal Vaccines Market Concentration, in 2020
Figure Middle East & Africa Meningococcal Vaccines Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Pneumonia
Figure Meningococcal Vaccines Demand in Pneumonia, 2016-2020, in USD Million
Figure Meningococcal Vaccines Demand in Pneumonia, 2016-2020, in Volume
6.1.2 Demand in Meningitis
Figure Meningococcal Vaccines Demand in Meningitis, 2016-2020, in USD Million
Figure Meningococcal Vaccines Demand in Meningitis, 2016-2020, in Volume
6.1.3 Demand in Bacteremia
Figure Meningococcal Vaccines Demand in Bacteremia, 2016-2020, in USD Million
Figure Meningococcal Vaccines Demand in Bacteremia, 2016-2020, in Volume
6.1.4 Demand in Others (Arthritis, Conjunctivitis, Urethritis)
Figure Meningococcal Vaccines Demand in Others (Arthritis, Conjunctivitis, Urethritis), 2016-2020, in USD Million
Figure Meningococcal Vaccines Demand in Others (Arthritis, Conjunctivitis, Urethritis), 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Meningococcal Vaccines Demand Forecast 2021-2026, by Application, in USD Million
Figure Meningococcal Vaccines Market Growth 2021-2026, by Application, in USD Million
Figure Meningococcal Vaccines Market Share in 2026, by Application, in USD Million
Table Meningococcal Vaccines Demand Forecast 2021-2026, by Application, in Volume
Table Meningococcal Vaccines Market Growth 2021-2026, by Application, in Volume
Table Meningococcal Vaccines Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Meningococcal Vaccines Production 2016-2020, by Region, in USD Million
Table Meningococcal Vaccines Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Meningococcal Vaccines Market 2016-2020, by Region, in USD Million
Table Global Meningococcal Vaccines Market Share 2016-2020, by Region, in USD Million
Table Global Meningococcal Vaccines Market 2016-2020, by Region, in Volume
Table Global Meningococcal Vaccines Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
Figure North America Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
Table North America Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
Figure Europe Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
Table Europe Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
Figure South America Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
Table South America Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Meningococcal Vaccines Market Forecast 2021-2026, by Region, in USD Million
Table Meningococcal Vaccines Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
1. Table Upstream Segment of Meningococcal Vaccines
2. Table Application Segment of Meningococcal Vaccines
3. Table Global Meningococcal Vaccines Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Menomune
5. Table Global Meningococcal Vaccines Market 2016-2020, by Type, in USD Million
6. Table Global Meningococcal Vaccines Market 2016-2020, by Type, in Volume
7. Table Global Meningococcal Vaccines Market Forecast 2021-2026, by Type, in USD Million
8. Table Global Meningococcal Vaccines Market Forecast 2021-2026, by Type, in Volume
9. Table GlaxoSmithKline Overview List
10. Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
11. Table JN-International Medical Overview List
12. Table Business Operation of JN-International Medical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table Novartis International Overview List
14. Table Business Operation of Novartis International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Sanofi Overview List
16. Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Pfizer Overview List
18. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Baxter International Overview List
20. Table Business Operation of Baxter International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Global Meningococcal Vaccines Sales Revenue 2016-2020, by Company, in USD Million
22. Table Global Meningococcal Vaccines Sales Revenue Share 2016-2020, by Company, in USD Million
23. Table Global Meningococcal Vaccines Sales Volume 2016-2020, by Company, in Volume
24. Table Global Meningococcal Vaccines Sales Volume Share 2016-2020, by Company, in Volume
25. Table Regional Demand Comparison List
26. Table Major Application in Different Regions
27. Table Meningococcal Vaccines Demand Forecast 2021-2026, by Application, in USD Million
28. Table Meningococcal Vaccines Demand Forecast 2021-2026, by Application, in Volume
29. Table Meningococcal Vaccines Market Growth 2021-2026, by Application, in Volume
30. Table Meningococcal Vaccines Market Share in 2026, by Application, in Volume
31. Table Meningococcal Vaccines Production 2016-2020, by Region, in USD Million
32. Table Meningococcal Vaccines Production 2016-2020, by Region, in Volume
33. Table Global Meningococcal Vaccines Market 2016-2020, by Region, in USD Million
34. Table Global Meningococcal Vaccines Market Share 2016-2020, by Region, in USD Million
35. Table Global Meningococcal Vaccines Market 2016-2020, by Region, in Volume
36. Table Global Meningococcal Vaccines Market Share 2016-2020, by Region, in Volume
37. Table North America Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
38. Table North America Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
39. Table Europe Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
40. Table Europe Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
41. Table Asia-Pacific Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
42. Table Asia-Pacific Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
43. Table South America Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
44. Table South America Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
45. Table Middle East & Africa Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
46. Table Middle East & Africa Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
47. Table Meningococcal Vaccines Market Forecast 2021-2026, by Region, in USD Million
48. Table Meningococcal Vaccines Market Forecast 2021-2026, by Region, in Volume
49. Table Price Factors List
List of Figure
List of Figure
1. Figure Meningococcal Vaccines Industry Chain Structure
2. Figure Global Meningococcal Vaccines Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Meningococcal Vaccines Market Growth 2016-2020, by Type, in Volume
4. Figure Global Meningococcal Vaccines Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Meningococcal Vaccines Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Meningococcal Vaccines Market Concentration, in 2020
7. Figure Europe Meningococcal Vaccines Market Market Concentration, in 2020
8. Figure Asia-Pacific Meningococcal Vaccines MMarket Concentration, in 2020
9. Figure South America Meningococcal Vaccines Market Concentration, in 2020
10. Figure Middle East & Africa Meningococcal Vaccines Market Concentration, in 2020
11. Figure Meningococcal Vaccines Demand in Pneumonia, 2016-2020, in USD Million
12. Figure Meningococcal Vaccines Demand in Pneumonia, 2016-2020, in Volume
13. Figure Meningococcal Vaccines Demand in Meningitis, 2016-2020, in USD Million
14. Figure Meningococcal Vaccines Demand in Meningitis, 2016-2020, in Volume
15. Figure Meningococcal Vaccines Demand in Bacteremia, 2016-2020, in USD Million
16. Figure Meningococcal Vaccines Demand in Bacteremia, 2016-2020, in Volume
17. Figure Meningococcal Vaccines Demand in Others (Arthritis, Conjunctivitis, Urethritis), 2016-2020, in USD Million
18. Figure Meningococcal Vaccines Demand in Others (Arthritis, Conjunctivitis, Urethritis), 2016-2020, in Volume
19. Figure Meningococcal Vaccines Market Growth 2021-2026, by Application, in USD Million
20. Figure Meningococcal Vaccines Market Share in 2026, by Application, in USD Million
21. Figure North America Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
22. Figure North America Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
23. Figure Europe Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
24. Figure Europe Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
25. Figure Asia-Pacific Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
26. Figure Asia-Pacific Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
27. Figure South America Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
28. Figure South America Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
29. Figure Middle East & Africa Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
30. Figure Middle East & Africa Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
31. Figure Marketing Channels Overview